NGS Library Preparation Market by Component Type (Instruments, Reagents & Consumables, Software & Services), Sequencing Type (Targeted Genome Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Workflow Stage, Application, End User - Global Fore
Description
The NGS Library Preparation Market was valued at USD 2.29 billion in 2024 and is projected to grow to USD 2.48 billion in 2025, with a CAGR of 9.07%, reaching USD 4.58 billion by 2032.
A strategic orientation to the evolution of library preparation workflows highlighting automation, reproducibility, and integration across research and clinical operations
Next-generation sequencing library preparation has transitioned from an artisanal laboratory activity into a highly engineered and modular discipline that underpins modern genomics. Advances in chemistry, instrumentation, and computational support have reshaped how samples are processed, how libraries are constructed and QCed, and how reproducibility is achieved across diverse applications. Laboratories now demand workflows that minimize hands-on time, reduce sample input requirements, and maintain consistency across high-throughput and clinical settings.
The introduction sets the stage for a strategic appraisal of current drivers, practical constraints, and emergent opportunities in library preparation. Key themes include the acceleration of automation, the rising importance of consumables and reagent innovations, the blending of wet-lab and informatics capabilities, and the growing influence of regulatory and reimbursement environments on adoption. Across research, clinical and industrial settings, stakeholders increasingly prioritize solutions that reduce variability, simplify integration with sequencing platforms, and provide transparent provenance for libraries. This executive summary synthesizes those themes and frames the subsequent discussion of technological shifts, tariff impacts, segmentation insights, regional dynamics, corporate strategies, recommended actions, and the research approach that underpins the analysis.
How automation, reagent innovation, and integrated informatics are collectively redefining library preparation workflows for higher throughput and clinical readiness
The landscape of library preparation is experiencing transformative shifts driven by converging technological and operational forces. Automation has migrated from bespoke robotics to standardized automated workstations and integrated library preparation systems that offer reproducible outcomes while lowering labor intensity. Parallel improvements in reagents and consumables - notably enzyme formulations, bead-based cleanups, and kit-based consolidation - have reduced hands-on steps, enabled lower input quantities, and supported diverse sample types ranging from single cells to formalin-fixed paraffin-embedded tissues. These innovations collectively enhance throughput and consistency while enabling new applications that were previously impractical.
Informatics has become integral to the library preparation lifecycle as analysis software and digital tracking systems attach provenance and quality metrics directly to libraries, enabling downstream comparability. The emergence of long-read technologies and single-cell sequencing places new demands on library prep chemistry and library construction strategies, encouraging suppliers to offer specialized kits and adapting instruments to support variable fragment lengths. Concurrently, regulatory expectations and laboratory accreditation needs have accelerated the adoption of validated workflows and consumable traceability, reinforcing the importance of vendor support, standardized documentation, and quality control modules. Taken together, these shifts are redefining how laboratories select solutions and partners, prioritizing end-to-end reliability and scalability over isolated component performance.
Understanding the operational and procurement consequences of 2025 tariff measures and how supply chain realignment is shaping access to instruments and consumables
The cumulative impact of United States tariffs introduced in 2025 has reverberated through supply chains and procurement strategies across the life sciences ecosystem, with particular consequences for capital-intensive instrumentation and recurring consumable purchases. Tariff-related cost pressures have prompted many organizations to re-evaluate sourcing strategies for instruments, reagents, and single-use consumables, and to accelerate negotiations with vendors for localized supply arrangements and longer-term commercial terms. As a result, procurement teams are placing greater emphasis on supplier diversification, total cost of ownership analyses, and contractual protections that mitigate exposure to tariff volatility.
Operational responses have included shifting manufacturing footprints, increasing regional distribution capabilities, and reconsidering inventory management policies to buffer against tariff-driven interruptions. Manufacturers and distributors have reacted with varying strategies: some have localized production or established regional packaging centers to minimize cross-border duties, while others have broadened partner networks to secure alternate suppliers for critical components such as enzymes, beads, and reagents. For laboratories, these shifts have translated into longer lead times for certain specialized systems, incremental cost premiums embedded in consumable pricing, and a renewed focus on supplier service performance and continuity planning. Ultimately, tariff-related disruptions have reinforced the importance of resilient supplier relationships, flexible procurement strategies, and an operational mindset that anticipates policy-driven trade changes.
A detailed segmentation perspective that links components, sequencing modalities, workflow stages, applications, and end-user priorities to R&D and purchasing behavior
Segmentation analysis reveals distinct product and user dynamics that inform where innovation and commercial focus are concentrated. Looking through the lens of component type, instruments, reagents and consumables, and software and services form the backbone of the ecosystem. Instruments encompass automated workstations, library preparation systems, and sequencers; each segment demands different capital commitment, support models, and upgrade paths. Reagents and consumables include beads, buffers, enzymes, and kits, where formulation, stability, and batch consistency drive user preference. Software and services span analysis software, consumables support, and setup assistance, connecting wet-lab output to actionable insights and operational continuity.
When evaluated by sequencing type, targeted genome sequencing, whole exome sequencing, and whole genome sequencing impose varying library construction requirements and quality thresholds, creating opportunities for specialized kits and workflows tailored to fragment size, coverage specificity, and enrichment chemistry. The workflow stage perspective-library amplification, library construction, quality control, and sample preparation-highlights where time, variability, and consumable consumption concentrate in laboratory processes. Application-based segmentation clarifies end-goal priorities: disease diagnosis demands validated utility and traceability, drug and biomarker research requires scalable and cost-efficient workflows for discovery, and precision medicine needs tailored workflows that maintain clinical-grade integrity. Finally, end-user segmentation differentiates academic and research institutes, contract research organizations, and pharmaceutical and biotechnology companies by purchasing cycles, throughput expectations, and regulatory intensity, shaping how offerings are packaged, supported, and priced.
Regional dynamics and adoption pathways that determine procurement strategies and supply chain resilience across the Americas, EMEA, and Asia-Pacific markets
Regional dynamics shape adoption patterns, supply chain decisions, and partnership models across the global library preparation landscape. The Americas have historically combined strong academic and commercial capital with an established vendor base and advanced clinical sequencing infrastructure; this environment encourages adoption of automated systems, customized reagent solutions, and integrated informatics that support translational research and diagnostic workflows. Procurement cycles in this region also reflect sophisticated purchasing models that weigh service, uptime, and long-term instrument support alongside initial acquisition costs.
Across Europe, the Middle East & Africa, diverse regulatory environments and varied public funding models create differentiated adoption pathways. Laboratories in this region often prioritize validated workflows and compliance-ready solutions, and regional centers of excellence drive demand for higher complexity applications. Supply chain resilience and local distribution partnerships play a critical role in ensuring consistent access to consumables and reagents. In the Asia-Pacific region, rapid expansion of sequencing capabilities, significant investment in genomics infrastructure, and increasing local manufacturing capacity are accelerating uptake of both entry-level and high-throughput systems. Regional manufacturers and distributors are strengthening their presence, offering competitive reagent kits and consumable alternatives while catering to large-scale population and public health initiatives. Each geography therefore presents distinct opportunity profiles for vendors and end users seeking to scale capabilities and manage operational risks.
How vendor strategies of integration, reagent differentiation, and service-driven models are shaping competitive advantage and customer retention
Key company strategies in the library preparation space emphasize platform integration, verticalized offerings, and service-led differentiation. Market participants are investing in modular platforms that combine automated workstations with validated reagent kits and embedded QC modules to simplify adoption and accelerate time-to-result. Many organizations are pursuing strategic partnerships and acquisitions to expand capability portfolios-linking chemistry expertise with automation and informatics-to deliver more complete, validated workflows that meet the demands of high-throughput and clinical laboratories.
In parallel, commercial models are evolving to include consumable-driven revenue streams and subscription-like service arrangements that provide predictable recurring income and closer customer engagement. Companies focusing on reagent excellence differentiate through proprietary enzyme formulations, bead technologies, and kit optimizations that reduce input requirements and improve library complexity. Others place greater emphasis on analysis software and cloud-enabled services that enable real-time QC assessment, data provenance tracking, and simplified handoffs to downstream bioinformatics pipelines. Across the competitive landscape, successful firms balance investment in R&D with scalable manufacturing capabilities and robust regulatory support to satisfy the requirements of diverse end users.
Practical, prioritized actions for suppliers and laboratories to strengthen resilience, improve adoption rates, and drive long-term operational value in library workflows
Industry leaders should prioritize a set of practical actions to strengthen resilience, accelerate adoption, and capture emerging opportunities. First, invest in validated, automated workflows that reduce hands-on time and minimize variability across operators and sites; coupling hardware with reagent kits and QC modules creates compelling value propositions for both research and clinical customers. Second, diversify supply chains by establishing regional manufacturing or distribution partnerships and by qualifying secondary suppliers for critical reagents and single-use components to mitigate the impact of policy-driven trade disruptions.
Third, expand service offerings beyond installation to include consumables support, software updates, and training programs that improve customer retention and lifecycle value. Fourth, develop flexible commercial models that accommodate different end-user needs-offering bundled systems for high-throughput customers while providing kit-centric, pay-per-use options for smaller laboratories. Fifth, invest in interoperability and open-data standards that facilitate integration with downstream bioinformatics and laboratory information management systems. Finally, maintain a rigorous regulatory and quality documentation framework that accelerates adoption in clinical settings and supports customer confidence in traceability and compliance. By acting on these priorities, organizations can strengthen their market position while helping customers achieve reproducible, scalable sequencing outcomes.
A rigorous mixed-methods approach combining primary interviews, technical literature synthesis, and expert validation to ensure dependable insights and practical relevance
The research methodology blends primary qualitative engagement with secondary evidence synthesis and iterative validation to ensure insight robustness. Primary inputs include structured interviews with laboratory directors, procurement leads, and technical managers across academic, contract research, and commercial environments, complemented by expert consultations with instrumentation engineers and reagent chemists. These conversations explored operational pain points, sourcing strategies, and the practical trade-offs that shape procurement decisions, providing first-hand perspectives on workflow adoption and supplier relationships.
Secondary research assembled publicly available technical white papers, peer-reviewed literature on library chemistry and protocol performance, regulatory guidance documents, and vendor technical specifications to contextualize the primary findings. Data triangulation balanced these inputs, cross-checking claims and identifying consistent patterns across sources. The analysis applied qualitative synthesis techniques to map technology maturity, workflow bottlenecks, and adoption drivers, while validation rounds with independent domain experts refined interpretations and ensured practical relevance. This mixed-methods approach prioritizes transparency, reproducibility, and alignment with operational realities in laboratories of varying scale and complexity.
A concise strategic synthesis outlining the essential priorities for stakeholders to enable reliable, scalable, and compliant library preparation operations
In conclusion, library preparation occupies a pivotal role in the broader genomics ecosystem as workflows become more automated, chemistry more specialized, and informatics more tightly coupled to wet-lab processes. Stakeholders who align investments with reproducibility, supply chain resilience, and integrated service models will be best positioned to meet expanding demand across research, clinical, and industrial applications. The interplay of reagent innovation, instrument automation, and regulatory expectations will continue to prioritize validated, end-to-end solutions that lower operational risk and simplify scalability.
Laboratories and vendors alike must adopt pragmatic strategies that anticipate policy and trade shifts, embrace interoperability, and foster deeper customer engagement through training and lifecycle services. Those that execute on these priorities will help drive the next wave of sequencing-enabled discovery and clinical translation by delivering library preparation workflows that are reliable, accessible, and optimized for real-world laboratory constraints. The synthesis provided here offers a framework for decision-makers to evaluate options, prioritize investments, and collaborate with suppliers to achieve consistent, high-quality sequencing outputs.
Note: PDF & Excel + Online Access - 1 Year
A strategic orientation to the evolution of library preparation workflows highlighting automation, reproducibility, and integration across research and clinical operations
Next-generation sequencing library preparation has transitioned from an artisanal laboratory activity into a highly engineered and modular discipline that underpins modern genomics. Advances in chemistry, instrumentation, and computational support have reshaped how samples are processed, how libraries are constructed and QCed, and how reproducibility is achieved across diverse applications. Laboratories now demand workflows that minimize hands-on time, reduce sample input requirements, and maintain consistency across high-throughput and clinical settings.
The introduction sets the stage for a strategic appraisal of current drivers, practical constraints, and emergent opportunities in library preparation. Key themes include the acceleration of automation, the rising importance of consumables and reagent innovations, the blending of wet-lab and informatics capabilities, and the growing influence of regulatory and reimbursement environments on adoption. Across research, clinical and industrial settings, stakeholders increasingly prioritize solutions that reduce variability, simplify integration with sequencing platforms, and provide transparent provenance for libraries. This executive summary synthesizes those themes and frames the subsequent discussion of technological shifts, tariff impacts, segmentation insights, regional dynamics, corporate strategies, recommended actions, and the research approach that underpins the analysis.
How automation, reagent innovation, and integrated informatics are collectively redefining library preparation workflows for higher throughput and clinical readiness
The landscape of library preparation is experiencing transformative shifts driven by converging technological and operational forces. Automation has migrated from bespoke robotics to standardized automated workstations and integrated library preparation systems that offer reproducible outcomes while lowering labor intensity. Parallel improvements in reagents and consumables - notably enzyme formulations, bead-based cleanups, and kit-based consolidation - have reduced hands-on steps, enabled lower input quantities, and supported diverse sample types ranging from single cells to formalin-fixed paraffin-embedded tissues. These innovations collectively enhance throughput and consistency while enabling new applications that were previously impractical.
Informatics has become integral to the library preparation lifecycle as analysis software and digital tracking systems attach provenance and quality metrics directly to libraries, enabling downstream comparability. The emergence of long-read technologies and single-cell sequencing places new demands on library prep chemistry and library construction strategies, encouraging suppliers to offer specialized kits and adapting instruments to support variable fragment lengths. Concurrently, regulatory expectations and laboratory accreditation needs have accelerated the adoption of validated workflows and consumable traceability, reinforcing the importance of vendor support, standardized documentation, and quality control modules. Taken together, these shifts are redefining how laboratories select solutions and partners, prioritizing end-to-end reliability and scalability over isolated component performance.
Understanding the operational and procurement consequences of 2025 tariff measures and how supply chain realignment is shaping access to instruments and consumables
The cumulative impact of United States tariffs introduced in 2025 has reverberated through supply chains and procurement strategies across the life sciences ecosystem, with particular consequences for capital-intensive instrumentation and recurring consumable purchases. Tariff-related cost pressures have prompted many organizations to re-evaluate sourcing strategies for instruments, reagents, and single-use consumables, and to accelerate negotiations with vendors for localized supply arrangements and longer-term commercial terms. As a result, procurement teams are placing greater emphasis on supplier diversification, total cost of ownership analyses, and contractual protections that mitigate exposure to tariff volatility.
Operational responses have included shifting manufacturing footprints, increasing regional distribution capabilities, and reconsidering inventory management policies to buffer against tariff-driven interruptions. Manufacturers and distributors have reacted with varying strategies: some have localized production or established regional packaging centers to minimize cross-border duties, while others have broadened partner networks to secure alternate suppliers for critical components such as enzymes, beads, and reagents. For laboratories, these shifts have translated into longer lead times for certain specialized systems, incremental cost premiums embedded in consumable pricing, and a renewed focus on supplier service performance and continuity planning. Ultimately, tariff-related disruptions have reinforced the importance of resilient supplier relationships, flexible procurement strategies, and an operational mindset that anticipates policy-driven trade changes.
A detailed segmentation perspective that links components, sequencing modalities, workflow stages, applications, and end-user priorities to R&D and purchasing behavior
Segmentation analysis reveals distinct product and user dynamics that inform where innovation and commercial focus are concentrated. Looking through the lens of component type, instruments, reagents and consumables, and software and services form the backbone of the ecosystem. Instruments encompass automated workstations, library preparation systems, and sequencers; each segment demands different capital commitment, support models, and upgrade paths. Reagents and consumables include beads, buffers, enzymes, and kits, where formulation, stability, and batch consistency drive user preference. Software and services span analysis software, consumables support, and setup assistance, connecting wet-lab output to actionable insights and operational continuity.
When evaluated by sequencing type, targeted genome sequencing, whole exome sequencing, and whole genome sequencing impose varying library construction requirements and quality thresholds, creating opportunities for specialized kits and workflows tailored to fragment size, coverage specificity, and enrichment chemistry. The workflow stage perspective-library amplification, library construction, quality control, and sample preparation-highlights where time, variability, and consumable consumption concentrate in laboratory processes. Application-based segmentation clarifies end-goal priorities: disease diagnosis demands validated utility and traceability, drug and biomarker research requires scalable and cost-efficient workflows for discovery, and precision medicine needs tailored workflows that maintain clinical-grade integrity. Finally, end-user segmentation differentiates academic and research institutes, contract research organizations, and pharmaceutical and biotechnology companies by purchasing cycles, throughput expectations, and regulatory intensity, shaping how offerings are packaged, supported, and priced.
Regional dynamics and adoption pathways that determine procurement strategies and supply chain resilience across the Americas, EMEA, and Asia-Pacific markets
Regional dynamics shape adoption patterns, supply chain decisions, and partnership models across the global library preparation landscape. The Americas have historically combined strong academic and commercial capital with an established vendor base and advanced clinical sequencing infrastructure; this environment encourages adoption of automated systems, customized reagent solutions, and integrated informatics that support translational research and diagnostic workflows. Procurement cycles in this region also reflect sophisticated purchasing models that weigh service, uptime, and long-term instrument support alongside initial acquisition costs.
Across Europe, the Middle East & Africa, diverse regulatory environments and varied public funding models create differentiated adoption pathways. Laboratories in this region often prioritize validated workflows and compliance-ready solutions, and regional centers of excellence drive demand for higher complexity applications. Supply chain resilience and local distribution partnerships play a critical role in ensuring consistent access to consumables and reagents. In the Asia-Pacific region, rapid expansion of sequencing capabilities, significant investment in genomics infrastructure, and increasing local manufacturing capacity are accelerating uptake of both entry-level and high-throughput systems. Regional manufacturers and distributors are strengthening their presence, offering competitive reagent kits and consumable alternatives while catering to large-scale population and public health initiatives. Each geography therefore presents distinct opportunity profiles for vendors and end users seeking to scale capabilities and manage operational risks.
How vendor strategies of integration, reagent differentiation, and service-driven models are shaping competitive advantage and customer retention
Key company strategies in the library preparation space emphasize platform integration, verticalized offerings, and service-led differentiation. Market participants are investing in modular platforms that combine automated workstations with validated reagent kits and embedded QC modules to simplify adoption and accelerate time-to-result. Many organizations are pursuing strategic partnerships and acquisitions to expand capability portfolios-linking chemistry expertise with automation and informatics-to deliver more complete, validated workflows that meet the demands of high-throughput and clinical laboratories.
In parallel, commercial models are evolving to include consumable-driven revenue streams and subscription-like service arrangements that provide predictable recurring income and closer customer engagement. Companies focusing on reagent excellence differentiate through proprietary enzyme formulations, bead technologies, and kit optimizations that reduce input requirements and improve library complexity. Others place greater emphasis on analysis software and cloud-enabled services that enable real-time QC assessment, data provenance tracking, and simplified handoffs to downstream bioinformatics pipelines. Across the competitive landscape, successful firms balance investment in R&D with scalable manufacturing capabilities and robust regulatory support to satisfy the requirements of diverse end users.
Practical, prioritized actions for suppliers and laboratories to strengthen resilience, improve adoption rates, and drive long-term operational value in library workflows
Industry leaders should prioritize a set of practical actions to strengthen resilience, accelerate adoption, and capture emerging opportunities. First, invest in validated, automated workflows that reduce hands-on time and minimize variability across operators and sites; coupling hardware with reagent kits and QC modules creates compelling value propositions for both research and clinical customers. Second, diversify supply chains by establishing regional manufacturing or distribution partnerships and by qualifying secondary suppliers for critical reagents and single-use components to mitigate the impact of policy-driven trade disruptions.
Third, expand service offerings beyond installation to include consumables support, software updates, and training programs that improve customer retention and lifecycle value. Fourth, develop flexible commercial models that accommodate different end-user needs-offering bundled systems for high-throughput customers while providing kit-centric, pay-per-use options for smaller laboratories. Fifth, invest in interoperability and open-data standards that facilitate integration with downstream bioinformatics and laboratory information management systems. Finally, maintain a rigorous regulatory and quality documentation framework that accelerates adoption in clinical settings and supports customer confidence in traceability and compliance. By acting on these priorities, organizations can strengthen their market position while helping customers achieve reproducible, scalable sequencing outcomes.
A rigorous mixed-methods approach combining primary interviews, technical literature synthesis, and expert validation to ensure dependable insights and practical relevance
The research methodology blends primary qualitative engagement with secondary evidence synthesis and iterative validation to ensure insight robustness. Primary inputs include structured interviews with laboratory directors, procurement leads, and technical managers across academic, contract research, and commercial environments, complemented by expert consultations with instrumentation engineers and reagent chemists. These conversations explored operational pain points, sourcing strategies, and the practical trade-offs that shape procurement decisions, providing first-hand perspectives on workflow adoption and supplier relationships.
Secondary research assembled publicly available technical white papers, peer-reviewed literature on library chemistry and protocol performance, regulatory guidance documents, and vendor technical specifications to contextualize the primary findings. Data triangulation balanced these inputs, cross-checking claims and identifying consistent patterns across sources. The analysis applied qualitative synthesis techniques to map technology maturity, workflow bottlenecks, and adoption drivers, while validation rounds with independent domain experts refined interpretations and ensured practical relevance. This mixed-methods approach prioritizes transparency, reproducibility, and alignment with operational realities in laboratories of varying scale and complexity.
A concise strategic synthesis outlining the essential priorities for stakeholders to enable reliable, scalable, and compliant library preparation operations
In conclusion, library preparation occupies a pivotal role in the broader genomics ecosystem as workflows become more automated, chemistry more specialized, and informatics more tightly coupled to wet-lab processes. Stakeholders who align investments with reproducibility, supply chain resilience, and integrated service models will be best positioned to meet expanding demand across research, clinical, and industrial applications. The interplay of reagent innovation, instrument automation, and regulatory expectations will continue to prioritize validated, end-to-end solutions that lower operational risk and simplify scalability.
Laboratories and vendors alike must adopt pragmatic strategies that anticipate policy and trade shifts, embrace interoperability, and foster deeper customer engagement through training and lifecycle services. Those that execute on these priorities will help drive the next wave of sequencing-enabled discovery and clinical translation by delivering library preparation workflows that are reliable, accessible, and optimized for real-world laboratory constraints. The synthesis provided here offers a framework for decision-makers to evaluate options, prioritize investments, and collaborate with suppliers to achieve consistent, high-quality sequencing outputs.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Implementation of automation platforms to increase throughput and reduce hands on time in high volume NGS library preparation workflows
- 5.2. Adoption of low input and ultra low input library kits for single cell and circulating tumor DNA analysis
- 5.3. Integration of dual indexing and unique molecular identifier technology to minimize sample cross contamination and bias in multiplexed NGS experiments
- 5.4. Rise of transposase based tagmentation methods for faster and simplified genomic DNA fragmentation and adapter insertion in library prep
- 5.5. Development of targeted enrichment panels with customizable probe design for oncology and infectious disease sequencing applications
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. NGS Library Preparation Market, by Component Type
- 8.1. Instruments
- 8.1.1. Automated Workstations
- 8.1.2. Library Preparation Systems
- 8.1.3. Sequencers
- 8.2. Reagents & Consumables
- 8.2.1. Beads
- 8.2.2. Buffers
- 8.2.3. Enzymes
- 8.2.4. Kits
- 8.3. Software & Services
- 8.3.1. Analysis Software
- 8.3.2. Consumables Support
- 8.3.3. Setup Assistance
- 9. NGS Library Preparation Market, by Sequencing Type
- 9.1. Targeted Genome Sequencing
- 9.2. Whole Exome Sequencing
- 9.3. Whole Genome Sequencing
- 10. NGS Library Preparation Market, by Workflow Stage
- 10.1. Library Amplification
- 10.2. Library Construction
- 10.3. Quality Control
- 10.4. Sample Preparation
- 11. NGS Library Preparation Market, by Application
- 11.1. Disease Diagnosis
- 11.2. Drug & Biomarker Research
- 11.3. Precision Medicine
- 12. NGS Library Preparation Market, by End User
- 12.1. Academic & Research Institutes
- 12.2. Contract Research Organizations
- 12.3. Pharmaceutical & Biotechnology Companies
- 13. NGS Library Preparation Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. NGS Library Preparation Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. NGS Library Preparation Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. 10x Genomics, Inc.
- 16.3.2. Agilent Technologies, Inc.
- 16.3.3. Beckman Coulter, Inc.
- 16.3.4. Becton, Dickinson and Company
- 16.3.5. BGI Genomics Co., Ltd.
- 16.3.6. Bio-Rad Laboratories, Inc.
- 16.3.7. Danaher Corporation
- 16.3.8. DNAnexus, Inc.
- 16.3.9. Dnastar, Inc.
- 16.3.10. Eurofins Scientific SE
- 16.3.11. F. Hoffmann-La Roche Ltd.
- 16.3.12. Illumina, Inc.
- 16.3.13. Integrated DNA Technologies, Inc.
- 16.3.14. Macrogen, Inc.
- 16.3.15. Merck KGaA
- 16.3.16. Meridian Bioscience, Inc.
- 16.3.17. New England Biolabs, Inc.
- 16.3.18. NimaGen B.V.
- 16.3.19. Pacific Biosciences of California, Inc.
- 16.3.20. PerkinElmer, Inc.
- 16.3.21. Promega Corporation
- 16.3.22. Qiagen GmbH
- 16.3.23. Tecan Trading AG
- 16.3.24. Thermo Fisher Scientific Inc.
- 16.3.25. Twist Bioscience Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
